MCG scientists investigate arthritis drug’s impact on Alzheimer’s disease

Nov 4, 2025

3 min

Qin Wang, PhD



According to the Alzheimer’s Association, more than 7 million Americans are living with Alzheimer’s disease, and one in nine of those people is 65 or older. Although that number is expected to grow, researchers at the Medical College of Georgia at Augusta University are making progress on studies that could turn into life-saving treatments.


Qin Wang, MD, PhD, professor in the Department of Neuroscience and Regenerative Medicine at MCG and Georgia Research Alliance Eminent Scholar in neuropharmacology, recently published a study titled “The PKCι‑β‑arrestin2 axis disrupts SORLA retrograde trafficking, driving its degradation and amyloid pathology in Alzheimer’s disease,” in Molecular Degeneration, a leading journal in neurodegeneration.


In the study, Wang and her team explored how certain proteins and enzymes interact in the brains of Alzheimer’s patients. Key players include the SORL1 gene, the PKCι enzyme and proteins SORLA, β‑arrestin2 and amyloid.



SORL1 encodes SORLA, which helps regulate amyloid. Amyloid can form plaque in the brain, contributing to Alzheimer’s. People with the disease often have lower SORLA levels, which amplifies plaque production.


“The goal is to increase SORLA levels in patients with AD. If we can boost it up, that would be great,” Wang said. “But if you want to know how to boost it up, you have to know how it is degraded, so that’s what our work is about – we’re trying to understand how its stability is regulated.”


Wang’s research team found that PKCι can add a phosphate group to SORLA, which helps SORLA interact with β‑arrestin2. The PKCι‑β‑arrestin2 axis leads to SORLA degradation, reducing its levels and allowing amyloid plaques to grow unchecked, thereby worsening the disease condition.


They discovered this by using biochemical methods and a mass spectrometer managed by Wenbo Zhi, PhD, at the Proteomics and Mass Spectrometry core lab at AU.


“We conducted biochemical studies and found that SORLA can be phosphorylated. We identified the phosphorylation site and the interacting enzymes,” Wang explained. “Using the mass spectrometer with PKCι, we saw increased phosphorylation of SORLA at certain sites. Preventing that could stop SORLA degradation.”



That’s where a rheumatoid arthritis drug called auranofin comes into play.


“While it is an arthritis drug, it can also inhibit the PKCι enzyme,” Wang explained.


The team conducted tests using Alzheimer’s mouse models and human iPS cells developed into neurons. For the mouse models, they treated the mice with auranofin for eight weeks, resulting in decreased amyloid levels, reduced neuroinflammation and improved cognitive function. Similar results were seen in human cells with increased SORLA levels and decreased amyloid levels.


“A good thing about this is, because this is an FDA-approved drug, it’s ready to be tested in Alzheimer’s patients,” Wang said. “People often worry about drug safety because of long-term use in chronic diseases like Alzheimer’s, but, in this case, existing safety data for chronic use gives a good starting point for testing in Alzheimer’s patients.

“I hope a drug company can pick that up for a trial with Alzheimer’s patients because we are trying to translate our bench work all the way to the bedside for treatment,” she continued.


The study wraps up a five-year National Institute on Aging grant, a collaborative effort between Wang’s lab and the Kai Jiao, MD, PhD, lab in AU’s Center of Biotechnology and Genomic Medicine. Wang’s team is also working on other grant-funded Alzheimer’s-related projects and hopes to continue making advancements toward finding a cure for this debilitating disease.


“All of our projects share the goal of finding a better treatment,” Wang said. “Related to this project in particular, we want to know how the SORLA protein works in different types of brain cells, given the brain’s complexity. Then we can determine how to specifically target that protein to develop more effective therapies.”


Qin Wang, MD, PhD, researches the neuropharmacology and signaling mechanisms underlying neurological and psychiatric disorders. If you're interested in learning more about her work or booking an interview,  simply click on her icon now to arrange a time to talk.



Connect with:
Qin Wang, PhD

Qin Wang, PhD

Professor of Neuroscience & Regenerative Medicine

Qin Wang researches the neuropharmacology and signaling mechanisms underlying neurological and psychiatric disorders.

Neurological DisordersRegenerative MedicineMolecular NeuropharmacologyNeuroscienceNeuropharmacology
Powered by

You might also like...

Check out some other posts from Augusta University

When Science Can't Be Repeated: Tackling a Crisis in Research featured image

3 min

When Science Can't Be Repeated: Tackling a Crisis in Research

Science depends on a simple but critical principle: Research findings should be reliable enough that other researchers can reproduce them. But what happens when they can't? Biomedical research is confronting what has become known as the “reproducibility crisis,” with major scientific journals estimating that more than 80% of published biomedical research is negatively affected by defects that can make findings non-reproducible or unusable. Now, researchers at Augusta University are taking a closer look at why research goes wrong – and, more importantly, whether those problems can be prevented before findings are published. Backed by a new $2.5 million R01 grant from the National Institutes of Health, researchers in Augusta University's School of Public Health will identify common research defects and develop strategies to help scientists avoid them. The project is led by E. Andrew Balas, MD, PhD, a professor in the Department of Health Management, Economics, and Policy who has spent more than a decade studying the research process itself. “Research quality is not only a matter of detecting errors after they occur. The critical question is, how can we understand the conditions that produce research defects and develop effective ways to prevent them before they compromise scientific results?”  E. Andrew Balas, MD, PhD The consequences extend well beyond the laboratory. Unreliable findings can influence patient care, waste research funding and send other scientists down paths built on results that were never dependable. They can also contribute to something increasingly important for the scientific community: declining public trust. The Augusta University team plans to create a database of common research defects and examine which stages of the research process are particularly vulnerable. Researchers also envision a tool that could eventually allow scientists to enter information about their methodology and identify potential problems before completing and publishing their work. Wendy Burnett, PhD, an assistant professor in the School of Public Health and co-investigator on the study, summed up the stakes: “Years of work and substantial funding may be invested in studies based on results that were never dependable.”  Wendy Burnett, PhD The interdisciplinary project will also examine the human side of the problem, gathering perspectives from researchers, peer reviewers and journal editors to better understand why research defects happen and what may prevent people from recognizing or addressing them. Ultimately, the research asks a question that goes to the heart of modern science: How can we make research more trustworthy before mistakes become part of the scientific record? After the project is complete, Balas and his team hope the results will ultimately impact science and society in many significant ways. “Research has made wonders in our lives – we have life-saving drugs, we have a lifestyle that is healthier than ever before and so forth. If research could produce more valuable, useful, trustworthy, reproducible results, then we will all be better, and it should also increase public trust in research.” For media covering scientific integrity, biomedical research, public trust in science, research funding, peer review or the reproducibility crisis, this work offers a timely look at how the scientific community can improve not only what it discovers, but how those discoveries are made.

Cybersecurity Meets AI: Preparing the Next Generation for a New Kind of Digital Workforce featured image

3 min

Cybersecurity Meets AI: Preparing the Next Generation for a New Kind of Digital Workforce

Cybersecurity and artificial intelligence are rapidly becoming interconnected – creating new opportunities, new vulnerabilities and a growing need for professionals who understand both. At Augusta University, a new $2 million grant from the National Science Foundation will help prepare the next generation of professionals to work at that intersection. The School of Computer and Cyber Sciences received the award through the NSF’s Artificial Intelligence and Cybersecurity Education Innovation and Scholarship for Service Program. The funding will support Augusta University Government-Ready Experts in Resilient CyberAI, or AUGER CyberAI. Michael Nowatkowski, PhD, professor and director of Augusta University’s Cyber Institute and head of Cyber Programs of Study, is the project’s principal investigator. The program reflects a fundamental shift in cybersecurity education. AI can be used as a tool to strengthen cybersecurity, but AI technologies themselves must also be secured. Augusta University is responding by integrating more AI into its cybersecurity curriculum, rather than treating the two disciplines as entirely separate fields. Participating undergraduate, master’s and doctoral students will take at least four cybersecurity courses and two artificial intelligence courses. Students can receive up to three years of funding covering tuition and fees, along with annual stipends of $27,000 for undergraduate students and $37,000 for graduate students. In return, graduates will put those skills to work in public service, with participants required to work for a federal executive branch agency for the same number of years they receive funding. If federal employment is unavailable, the obligation can be fulfilled through state or local government employment. “As cybersecurity and artificial intelligence become more interconnected, we have a responsibility to prepare students with the knowledge and experience needed to meet the evolving needs of the workforce.” – Alex Schwarzmann, PhD Schwarzmann, dean of Augusta University’s School of Computer and Cyber Sciences, says AUGER CyberAI will allow the university to invest in students while mentoring a new generation of professionals prepared to serve the nation. The first cohort will begin in fall 2026, with approximately seven students expected in the inaugural group and another seven anticipated in 2027. Experts on Cybersecurity, AI and the Workforce Michael Nowatkowski is a leading cybersecurity expert whose areas of expertise include defensive cyber operations, cyber operations education, control system security, medical device security and information assurance. He can provide insight into how AI is changing cybersecurity, the skills future cyber professionals will require and how universities can prepare students for an evolving threat environment. View his profile Alex Schwarzmann is a nationally recognized expert in computer science, cybersecurity and distributed systems. His research has been supported by numerous grants from the National Science Foundation and other agencies, and he can provide perspective on computer science education, the changing technology workforce and the growing intersection between AI and cybersecurity.  View his profile For journalists covering artificial intelligence, cybersecurity, cyber threats, technology education, workforce development, government cybersecurity or the future of the technology workforce, Nowatkowski and Schwarzmann can provide expert analysis and perspective. If you’re interested in speaking with Michael Nowatkowski, PhD, or Alex Schwarzmann, PhD, about cybersecurity, artificial intelligence and preparing the next generation of cyber professionals, click on their profiles below.

Beyond the Cadaver: How Virtual Anatomy Is Changing the Way Future Nurse Anesthetists Learn featured image

2 min

Beyond the Cadaver: How Virtual Anatomy Is Changing the Way Future Nurse Anesthetists Learn

For generations, learning human anatomy has meant textbooks, models and traditional cadaver labs. At Augusta University, future nurse anesthetists are also learning with technology that puts a digitized human cadaver at their fingertips. The College of Nursing's Nursing Anesthesia Program is using Anatomage Tables, advanced anatomy systems that allow students to explore the human body digitally and in significant detail. Augusta University's program is the first Certified Registered Nurse Anesthetist program in the nation to have two Anatomage Tables. According to the university, fewer than 10% of programs have access to even one. Michael Wilson, DNAP, assistant professor at Augusta University, regularly teaches with the technology and has played an important role in expanding its use within the program. For students preparing to work in anesthesia, being able to clearly visualize anatomy has direct relevance to their education. The tables can clearly display the nervous system, for example, helping students learn about nerve blocks that are critical to regional anesthesia. “There’s no guesswork with the table.” – Michael Wilson, DNAP Wilson says the technology also allows him to ask students much more detailed anatomy questions than would be possible using a traditional cadaver. Students can book independent lab time with the tables, giving them an opportunity to control the technology themselves and use it for additional study and practice. The technology is already becoming part of how students are assessed. Wilson administered the program's first lab practical using an Anatomage Table, an experience he described as a “huge success and landmark for the university.” Bringing Technology Into Health Sciences Education Wilson combines a background in anatomy and physiology with an interest in technology, using that experience to integrate Anatomage into nursing anesthesia education and explore its potential use with Adult Gerontology Acute Care Nurse Practitioner students. The technology builds on NAP’s legacy of innovation and excellence. Established in 1994, it was among Georgia’s first public programs, is now among the five largest in the nation and has been nationally recognized by U.S. News & World Report as a top graduate program.

View all posts